期刊文献+

CYP1A1基因多态性与宫颈癌遗传易感性的关系 被引量:3

Relationship between CYP1A1 gene polymorphism and genetic susceptibility of cervical carcinoma
原文传递
导出
摘要 目的探讨CYP1A1基因Exon7位点和Msp1位点多态性与宫颈癌遗传易感性的关系。方法 280例老年宫颈癌患者为实验组,280例健康体检者为对照组,用CR-RELP技术和ASA-PCR技术分别检测两组人群Msp1位点和Exon7位点的多态性。结果两组在CYP1A1Ⅱe/Val位点分布上差异有统计学意义(P<0.05);且携带Ⅱe/Val基因型的个体发生宫颈癌的危险是携带Ⅱe/Ⅱe基因型个体的2.473倍。而两组的Msp1基因型多态性分布频率及OR值均无统计学差异(P>0.05)。结论 CYP1A1Exon7基因多态性是发生宫颈癌的危险因素,有可能成为宫颈癌遗传易感标记物。Msp1位点多态性与宫颈癌易感性可能无关。 Objective To explore the relationship between the polymorphism of CYPlA1 gene and the genetic susceptibility to cervical carcinoma.Methods The polymorphism of CYPlA1 gene at Msp1 and Exon7 locus was detected with CR-RELP and PCR-RFLP in 280 patients with cervical carcinoma(group A) and 280 healthy control subjects(group B).Results There was a significant difference in the CYP1A1 Exon7 genotype frequencies of Ⅱe/Va between two groups(P〈0.05) and the increaed risk for developing cervical carcinoma in people who carried Ⅱe/Val genetype was 2.473 times as much as that in those who carried Ⅱe/Ⅱe.There was no significant difference in the frequency of CYP1A1 Msp1 between two groups(P〉0.05).Conclusion The CYP1A1 Exon7 gene polymorphism,but not the CYP1A1 Msp1 gene polymorphism,is the risk factor for cervical carcinoma and could become a marker for genetic susceptibility of cervical carcinoma.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第21期2562-2564,共3页 Jiangsu Medical Journal
关键词 CYP1A1基因多态性 宫颈癌 遗传易感性 CYP1A1 gene polymorphism Cervical carcinoma Genetic susceptibility
  • 相关文献

参考文献6

  • 1郝瑞凤(综述),王培玉(审校).宫颈癌流行病学及高危因素探讨[J].医学综述,2009,15(10):1495-1498. 被引量:42
  • 2郑波 黄海燕 刘建军等.CYPlAl、CYP2E1基因多态性与癌症易感性的研究进展.医学综述,2009,:243-245.
  • 3Gra OA, Kozhekbaeva ZHM, Litvinov VI, et al. Analysis of genetic predisposition to pulmonary tuberculosis in native Russians[J]. Russian Journal of Genetic, 2010, 46 ( 2 ) : 262- 271.
  • 4刘群,刘杰,宋宝,王哲海.CYP1A1、GSTM1基因多态性与肺癌遗传易感性的关系[J].山东医药,2008,48(9):32-34. 被引量:8
  • 5Sin4gh N, Mitra AK, Kumar V, et al. Association of CYP1A1 polymorphisms with breast cancer in north Indian women[J]. Oncoi Bes, 2008,16 (12) : 587-597.
  • 6Kochetova OV, Korytina GF, Akhmadishina LZ, et at. Analysis of the cytochrome P450 1 A1 (CYP1 A1 ) gene polymorphism in the ethnic groups of the republic of Bashkortostan[J]. Russian Journal of Genetics,2008,44(12) : 1677-1683.

二级参考文献13

共引文献48

同被引文献22

  • 1卢慧,杨磊.细胞色素P4501 A1基因多态性与肿瘤的易感性研究[J].农垦医学,2006,28(6):458-461. 被引量:2
  • 2Forouzanfar MH,Foreman KJ,Delossantos AM,et al.Breast and cervical cancer in 187 countries between 1980 and 2010:a systematic analysis[J].Lancet,2011,378(9801):1461-1484.
  • 3Schiffman M,Castle PE,Jeronimo J,et al.Human papillomavirvs and cervical cancer[J].Lancet,2007,370(9590):890-907.
  • 4Huang M,Chen Q,Xiao J,et al.CYP1A1 Ile462Val is a risk factor for ovarian cancer development[J].Cytokine,2012,58(1):73-78.
  • 5Wang JJ,Zheng Y,Sun L,et al.CYP1A1 Ile462Val polymorphism and susceptibility to lung cancer:a metaanalysis based on32studies[J].Eur J Cancer Prev,2011,20(6):445-452.
  • 6Ahn T,Yun CH.Molecular mechanisms regulating the mitochondrial targeting of microsomal cytochrome P450 enzymes[J].Curr Drug Metab,2010,11(10):830-839.
  • 7Wienkers LC,Heath TG.Predicting in vivo drug interactions from in vitro drug discovery data[J].Nat Rev Drug Discov,2005,4(10):825-33.
  • 8Sissung TM,Price DK,Sparreboom A,et al.Pharmacogenetics and regulation of human cytochrome P450 1 BI:implications in hormone mediated tumor metabolism and a novel target for therapeutic intervention[J].Mol Cancer Res,2006,4(3):135-150.
  • 9Oyama T,Sugio K,Isse T,et al.Expression of cytochrome P450 in non-small cell lung cancer[J].Front Biosci,2008(13):5787-5793.
  • 10Bozina N,Bradamane V,lovric M.Genetic polymorphism of metabolic enzymes P450(CYP)as a susceptibility factor for drug response toxicity and cancer risk[J].Arh Hig Rada Toksikol,2009,60(2):217-242.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部